Endothelin and cardiovascular remodelling in end-stage renal disease

被引:86
|
作者
Demuth, K
Blacher, J
Guerin, AP
Benoit, MO
Moatti, N
Safar, ME
London, GM
机构
[1] Hop Manhes, Serv Nephrol Hemodialyse, F-91700 Fleury Merogis, France
[2] Broussais Hop, Dept Biochem, Paris, France
[3] INSERM, U337, Paris, France
关键词
endothelin; ESRD; cardiovascular remodelling;
D O I
10.1093/oxfordjournals.ndt.a027833
中图分类号
R3 [基础医学]; R4 [临床医学];
学科分类号
1001 ; 1002 ; 100602 ;
摘要
Background. Plasma endothelin (ET) is elevated in end-stage renal disease (ESRD), but the origin and consequences of this increase remain unclear. In the present study we analysed the relationships between plasma ET levels and cardiovascular alterations in ESRD. Methods and results. Common carotid artery (CCA) intima-media thickness (IMT) and diameter, atherosclerotic plaque occurrence, and left ventricular (LV) geometry and function were determined by ultrasound imaging in 76 haemodialysis patients and in 57 age-, sex-, and blood pressure-matched controls. Arterial stiffness was evaluated via carotid-femoral pulse wave velocity (CF-PWV), forearm post-ischaemic vasodilation was measured by venous plethysmography, and plasma ET levels were determined using a specific immunoenzymoassay. Compared with controls, ESRD patients had elevated plasma ET levels (1.6 +/- 1.4 vs 4.6 +/- 3.8 pg/ml; P < 0.001), increased LV mass (P < 0.001), increased CCA-IMT (P < 0.001), a higher prevalence of atherosclerotic plaques (P < 0.001) and increased CF-PWV (P < 0.01). Plasma ET levels correlated positively with LV outflow velocity integral(r = 0.57; P < 0.0001), stroke index (P < 0.01), and baseline forearm blood flow (P < 0.001) which were all significantly higher in ESRD patients than in controls (P < 0.01). After adjustment for age, blood pressure, haemoglobin levels, gender and body dimensions, plasma ET levels were significantly correlated to LV mass (r = 0.46; P < 0.001), CCA-IMT and CCA intima -media cross-sectional area (r = 0.41; P < 0.001), and CF-PWV (P < 0.05). Post-ischaemic forearm vasodilation was decreased in ESRD (85 +/- 31 vs 119 +/- 28%; P < 0.001) and there was a negative correlation between post-ichaemic flow recovery and ET levels (r = -0.49; P < 0.001). In ESRD patients, plasma ET levels were positively and independently correlated with the prevalence of CCA atherosclerotic plaque (P < 0.01). Conclusions. These results indicate that the increased plasma ET levels in ESRD patients are associated with left ventricular hypertrophy and arterial intima-media thickening, suggesting that increased ET concentrations in ESRD patients may be of pathophysiological significance in the process of cardiovascular remodelling.
引用
收藏
页码:375 / 383
页数:9
相关论文
共 50 条
  • [1] Cardiovascular disease in end-stage renal disease
    Park, Jung Tak
    Oh, Hyung Jung
    Kang, Shin-Wook
    JOURNAL OF THE KOREAN MEDICAL ASSOCIATION, 2013, 56 (07): : 576 - 582
  • [2] The Cardiovascular Burden in End-Stage Renal Disease
    Cozzolino, Mario
    Galassi, Andrea
    Pivari, Francesca
    Ciceri, Paola
    Conte, Ferruccio
    EXPANDED HEMODIALYSIS: INNOVATIVE CLINICAL APPROACH IN DIALYSIS, 2017, 191 : 44 - 57
  • [3] Cardiovascular calcification in end-stage renal disease
    Salusky, IB
    Goodman, WG
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2002, 17 (02) : 336 - 339
  • [4] Cardiovascular mortality in end-stage renal disease
    Collins, AJ
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 163 - 167
  • [5] Cardiovascular disease in end-stage renal disease patients
    Collins, AJ
    Li, SL
    Ma, JZ
    Herzog, C
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2001, 38 (04) : S26 - S29
  • [6] The epidemic of cardiovascular disease in end-stage renal disease
    Brenner, RM
    Wrone, EM
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 1999, 8 (03): : 365 - 369
  • [7] REVERSE VENTRICULAR REMODELLING IN A PATIENT WITH END-STAGE RENAL DISEASE
    Grande, D.
    Parisi, G.
    Gioia, M.
    Lisi, F.
    Bellino, M.
    Amato, L.
    Caldarola, P.
    Ciccone, M.
    Iacoviello, M.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0E) : E179 - E179
  • [8] Cardiovascular complications of end-stage renal disease: An overview
    Alpert, MA
    AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04): : 161 - 162
  • [9] Epidemiology of cardiovascular disease in end-stage renal failure
    Kessler, M
    NEPHROLOGIE, 2002, 23 (07): : 361 - 365
  • [10] Cardiovascular complications in pediatric end-stage renal disease
    Rulan S. Parekh
    Samuel S. Gidding
    Pediatric Nephrology, 2005, 20 : 125 - 131